Patient care navigation and health copilot AI
RTHM
RTHM is a patient-facing intelligence platform and virtual-care pathway for complex chronic conditions such as Long COVID, ME/CFS, POTS, MCAS, hEDS, and related illnesses. It gathers patient-entered data, uploaded records, HIE-retrieved records, labs, symptoms, questionnaires, and AI chat context to generate a health roadmap, research-informed hypotheses, and testing or treatment suggestions. The agency upside is meaningful because it can help patients understand and organize poorly served conditions. The CAIHL caveat is that the same platform can route patients into paid medications, labs, and clinic services, while data-use terms allow de-identified sharing and model/service improvement uses.
Public-source research has been drafted; final human publication review and change-log detail are still required.
Summary judgment · 70% toward patient-directed
Potentially agency-expanding, with vendor-funnel and data-use caveats
RTHM gives patients condition-specific AI synthesis and action support, but the roadmap can route toward paid services, and legal terms permit de-identified sharing plus model and service improvement uses.
Patient agency
How this tool changes agency
The health roadmap, research corner, shareable insights, appointment-question support, medication requests, lab pathways, and clinic escalation are explicitly action-oriented.
Use is patient-initiated and the intelligence platform is described as free, and patients may skip HIE record retrieval and upload records manually. Paid care options are state-limited and may require eligibility, insurance compatibility, or cash payment.
Patient-facing signals
Who does this AI serve?
The intelligence platform is presented for patients and is free to use, but it is also integrated with paid medication, lab, and clinic pathways operated through RTHM and affiliated medical groups.
Can patients tell AI is involved?
The public site and FAQ repeatedly describe AI-powered insights, a HIPAA-compliant AI chat, an AI navigation assistant, and AI-generated roadmap functions.
Can patients meaningfully choose?
Use is patient-initiated and the intelligence platform is described as free, and patients may skip HIE record retrieval and upload records manually. Paid care options are state-limited and may require eligibility, insurance compatibility, or cash payment.
Can patients correct or challenge what the AI produces?
Public FAQ materials describe profile deletion, retaking questionnaires, support contact, bug reports, and chat feedback. Submitted medication intake forms cannot be changed for regulatory reasons, and app-level editing, audit, and challenge workflows for roadmap suggestions need verification.
Does it help patients understand or act?
The health roadmap, research corner, shareable insights, appointment-question support, medication requests, lab pathways, and clinic escalation are explicitly action-oriented.
Text findings
Who is left out or burdened?
State, cost, insurance, digital, and data-completeness limits
Clinical services and medication access are limited by state, age, insurance, payment model, and U.S. availability. The platform is browser-based and data-heavy. Patients without recent records, HIE coverage, digital access, English literacy, clinician support, or affordable out-of-network care may face added burden.
What happens to patient data?
Meaningful public detail, with secondary-use and HIE-return caveats
RTHM says health data is encrypted, used for personalized insights and service improvement, not sold as identifiable data, and deletable through account deletion. The support FAQ says HIE record retrieval can require returning some prescriptions, visit notes, and non-psychiatric questionnaire data to exchanges. Terms allow de-identified disclosure, aggregation, sale, or other use for analytics, research, or other purposes, and allow submitted information to improve services and underlying AI models.
Are the clinical boundaries clear?
Partial to clear
Terms say RTHM itself is not a medical group, clinical care is provided by independent RTHM-branded practices, the platform is not for emergencies, and Ana does not diagnose or treat. Support materials also warn the AI can generate incomplete or incorrect suggestions and should be verified with a care team.
Who defined what good looks like?
Vendor-defined, with patient advisory and beta-testing claims
RTHM says its AI was tested internally, with a patient advisory group, and with nearly 200 beta users. Public evidence did not show independent safety, equity, privacy, model-performance, or patient-outcome evaluation.
Review method
Deep public-source review of RTHM homepage, staging homepage, support FAQ, medications page, clinic page, treatments page, about page, privacy policy, terms of use, and LegitScript certification checker. No login, app walkthrough, vendor interview, clinician interview, independent model evaluation, or independent outcomes review.
Draft profile · Medium draft, official sources only